AU538311B2 - Treatment of disorders of calcium metabolism - Google Patents

Treatment of disorders of calcium metabolism

Info

Publication number
AU538311B2
AU538311B2 AU65960/81A AU538311DA AU538311B2 AU 538311 B2 AU538311 B2 AU 538311B2 AU 65960/81 A AU65960/81 A AU 65960/81A AU 538311D A AU538311D A AU 538311DA AU 538311 B2 AU538311 B2 AU 538311B2
Authority
AU
Australia
Prior art keywords
disorders
treatment
calcium metabolism
metabolism
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU65960/81A
Inventor
Matthius Potokar
Manfred Schmidt-Dunker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Application granted granted Critical
Publication of AU538311B2 publication Critical patent/AU538311B2/en
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
AU65960/81A 1981-01-02 1981-01-02 Treatment of disorders of calcium metabolism Expired - Fee Related AU538311B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU6596080A AU6596080A (en) 1981-01-02 1981-01-02 Treatment of disorders of calcium metabolism

Publications (1)

Publication Number Publication Date
AU538311B2 true AU538311B2 (en) 1984-08-09

Family

ID=3750587

Family Applications (2)

Application Number Title Priority Date Filing Date
AU6596080A Pending AU6596080A (en) 1981-01-02 1981-01-02 Treatment of disorders of calcium metabolism
AU65960/81A Expired - Fee Related AU538311B2 (en) 1981-01-02 1981-01-02 Treatment of disorders of calcium metabolism

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU6596080A Pending AU6596080A (en) 1981-01-02 1981-01-02 Treatment of disorders of calcium metabolism

Country Status (1)

Country Link
AU (2) AU6596080A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760021A (en) * 1992-05-29 1998-06-02 The Procter & Gamble Company Phosphonocarboxylate compounds pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application

Also Published As

Publication number Publication date
AU6596080A (en) 1981-06-25

Similar Documents

Publication Publication Date Title
DE3565695D1 (en) Process for the treatment of aluminium surfaces
AU580820B2 (en) Treatment of obesity
AU3064184A (en) Improved compositions for the treatment of psoriasis
AU571626B2 (en) Treatment of symptoms of hypercorticordism using etiocholanolones
ZA855916B (en) Treatment of skin disorders
GB2103088B (en) Treatment of arthritis
AU3813289A (en) Treatment of gastrointestinal disorders
ZA867530B (en) Composition for the treatment of acne
AU581672B2 (en) Novel treatment
AU8248182A (en) Wastewater treatment
DE3261704D1 (en) Apparatus for the application of acupuncture-type therapeutical treatments
AU538311B2 (en) Treatment of disorders of calcium metabolism
AU8770282A (en) Composition for the treatment of atherosclerosis
GB8428722D0 (en) Treatment of pipelines
PH24312A (en) Treatment of osteoporosis
AU6596081A (en) Treatment of disorders of calcium metabolism
ZA852638B (en) Oxindole compounds for the treatment of epilepsy
GB8715914D0 (en) Treatment of cerabral disorders
ZA835997B (en) Treatment of zeolites
GB2110088B (en) Compositions for the treatment of acne
GB2093727B (en) Treatment of sludge
PH21642A (en) Treatment of osteoporosis
AU4895785A (en) Wastewater treatment process
AU557081B2 (en) Treatment of ion-exchange membrane
DE3167587D1 (en) Composition for the treatment of acne